SYVN1: A Promising Drug Target and Biomarker for the Treatment of Inflammatory Neurodegenerative Diseases

Target Name: SYVN1

NCBI ID: G84447

SYVN1: A Promising Drug Target and Biomarker for the Treatment of Inflammatory Neurodegenerative Diseases

Introduction

SYNOVIO is a family of proteins that play a pivotal role in the regulation of synovial inflammation and tissue repair. The SYVN1 gene, located on chromosome 6p21.1, encodes for a protein known as ring-type E3 ubiquitin transferase synoviolin (SYVN1) (1 ). As a member of the SYVN family, SYVN1 is involved in the ubiquitination and degradation of intracellular proteins, which are involved in various cellular processes, including inflammation, cell signaling, and tissue repair. The dysregulation of SYVN1 has been implicated in the development and progression of inflammatory neurodegenerative diseases, including rheumatoid arthritis, psoriatic arthritis, and neuroinflammatory diseases.

SYVN1 as a Drug Target

SYVN1 has emerged as a promising drug target due to its involvement in the regulation of inflammation and cellular signaling. Several studies have demonstrated that inhibition of SYVN1 can reduce the production of pro-inflammatory cytokines and improve the expression of anti-inflammatory cytokines, such as IL-10, in mouse models of inflammatory neurodegenerative diseases (4,5). Additionally, knockdown of SYVN1 has been shown to reduce the expression of other genes involved in inflammation and neurodegeneration, including the T-cell receptor.

SYVN1 as a Biomarker

The dysregulation of SYVN1 has also been implicated in the development of inflammatory neurodegenerative diseases. Several studies have shown that increased levels of SYVN1 are associated with the development of neuroinflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, and multiple sclerosis (7,8). Additionally, decreased levels of SYVN1 have been observed in the brains of patients with neurodegenerative diseases, suggesting that it may play a role in the pathogenesis of these diseases.

Expression of SYVN1 in Neurodegenerative Diseases

SYVN1 has been shown to be expressed in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease (10,11). In addition, increased levels of SYVN1 have been observed in the brains of patients with neurodegenerative diseases, which may indicate a role for this protein in the development and progression of these conditions.

Conclusion

In conclusion, SYVN1 is a promising drug target and biomarker for the treatment of inflammatory neurodegenerative diseases. The dysregulation of SYVN1 has been implicated in the development and progression of various neuroinflammatory diseases, and inhibition of this protein has been shown to improve the expression of anti- -inflammatory cytokines and reduce the production of pro-inflammatory cytokines. Further research is needed to fully understand the role of SYVN1 in the development and treatment of inflammatory neurodegenerative diseases.

Protein Name: Synoviolin 1

Functions: E3 ubiquitin-protein ligase which accepts ubiquitin specifically from endoplasmic reticulum-associated UBC7 E2 ligase and transfers it to substrates, promoting their degradation (PubMed:12459480, PubMed:12646171, PubMed:12975321, PubMed:14593114, PubMed:16289116, PubMed:16847254, PubMed:17059562, PubMed:17141218, PubMed:17170702, PubMed:22607976, PubMed:26471130, PubMed:28827405). Component of the endoplasmic reticulum quality control (ERQC) system also called ER-associated degradation (ERAD) involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins (PubMed:12459480, PubMed:12646171, PubMed:12975321, PubMed:14593114, PubMed:16289116, PubMed:16847254, PubMed:17059562, PubMed:17141218, PubMed:17170702, PubMed:22607976, PubMed:26471130, PubMed:28842558). Also promotes the degradation of normal but naturally short-lived proteins such as SGK. Protects cells from ER stress-induced apoptosis. Protects neurons from apoptosis induced by polyglutamine-expanded huntingtin (HTT) or unfolded GPR37 by promoting their degradation (PubMed:17141218). Sequesters p53/TP53 in the cytoplasm and promotes its degradation, thereby negatively regulating its biological function in transcription, cell cycle regulation and apoptosis (PubMed:17170702). Mediates the ubiquitination and subsequent degradation of cytoplasmic NFE2L1 (By similarity). During the early stage of B cell development, required for degradation of the pre-B cell receptor (pre-BCR) complex, hence supporting further differentiation into mature B cells (By similarity)

More Common Targets